Re: Vivaglobin

[InfusionTx]

Yeah everything Marilyn said, LOL. But we do need to be sure to take note of the manufacturers recommendations. Unless you like going off label. There is extensive information specific to this product and the manufacturers directions and dosing and administration at the link below.   http://www.fda.gov/cber/label/igsczlb010906LB.pdf   Tony West, RN, CRNI Healix, Inc. Email: [EMAIL PROTECTED] or [EMAIL PROTECTED] SMS: [EMAIL PROTECTED] Cell: 214-674-4848   In a message dated 3/7/2006 12:07:41 P.M. Central Standard Time, [EMAIL PROTECTED] writes: SCIG has been done successfully with PID patients for years. It originated in Europe and a lit search will produce a fairly comprehensive review of the procedures, rates and associated outcomes. Since the SCIG procedure usually requires weekly administration, it is a viable option for those individuals who 1) do not want to miss work/school in order to receive IVIG in a more traditional setting and 2) are motivated to assume responsibility for self administration.. It is also popular choice in peds.   In Europe, SCIG is done using a 16% product. A similar product has not been available in the US, so providers have usually opted for a 10% product. The new ZLB Behring product, Vivaglobulin, will be the first 16% SCIG in the US.  Due to competition within the specialty pharmacy arena, your best & most readily available resources to learn more are a review of the published literature, support from the manufacturer, and the Immune Deficiency Foundation, as they have been investigating SCIG for years and offered a session on it at their national conference last year.   M Hanchett RN Director of Clinical Affairs IgG America From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of KayBeth Weibel, CRNI Sent: Monday, March  06, 2006 1:18 PM To: [EMAIL PROTECTED] Subject: Vivaglobin Hello,   I received notice today from the FDA of approval for “First Immune Globulin for Subcutaneous use”, Vivaglobin.  I have not administered IG subcutaneously before.  Does anybody have any experiences or comments?   Thanks   KayBeth Weibel, RN, CRNI Director of Nursing Services Infusion Network Falmouth, MA 02540 tel (508) 548-4266 fax (508) 540-7549